Cerity Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,343
| Closed | -$487K | – | 2561 |
|
|
2024
Q4 | $487K | Sell |
8,343
-5,426
| -39% | -$317K | ﹤0.01% | 1779 |
|
|
2024
Q3 | $920K | Buy |
13,769
+900
| +7% | +$60.1K | ﹤0.01% | 1440 |
|
|
2024
Q2 | $1.53M | Sell |
12,869
-2,141
| -14% | -$254K | ﹤0.01% | 1039 |
|
|
2024
Q1 | $1.6M | Buy |
15,010
+9,384
| +167% | +$1,000K | ﹤0.01% | 1072 |
|
|
2023
Q4 | $560K | Buy |
5,626
+2,903
| +107% | +$289K | ﹤0.01% | 1218 |
|
|
2023
Q3 | $281K | Sell |
2,723
-2,612
| -49% | -$270K | ﹤0.01% | 1169 |
|
|
2023
Q2 | $648K | Buy |
5,335
+1,192
| +29% | +$145K | ﹤0.01% | 1079 |
|
|
2023
Q1 | $632K | Sell |
4,143
-3,149
| -43% | -$480K | ﹤0.01% | 1179 |
|
|
2022
Q4 | $1.31M | Buy |
7,292
+1,575
| +28% | +$283K | 0.01% | 623 |
|
|
2022
Q3 | $676K | Sell |
5,717
-574
| -9% | -$67.9K | 0.01% | 609 |
|
|
2022
Q2 | $898K | Buy |
6,291
+2,352
| +60% | +$336K | 0.01% | 573 |
|
|
2022
Q1 | $679K | Buy |
3,939
+229
| +6% | +$39.5K | 0.01% | 526 |
|
|
2021
Q4 | $947K | Buy |
3,710
+1,427
| +63% | +$364K | 0.01% | 449 |
|
|
2021
Q3 | $879K | Buy |
2,283
+283
| +14% | +$109K | 0.02% | 379 |
|
|
2021
Q2 | $470K | Sell |
2,000
-10
| -0.5% | -$2.35K | 0.01% | 483 |
|
|
2021
Q1 | $263K | Buy |
+2,010
| New | +$263K | 0.01% | 591 |
|